272 related articles for article (PubMed ID: 845807)
1. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
Garrett ER; Hunt CA
J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose.
Garrett ER; Jackson AJ
J Pharm Sci; 1979 Jun; 68(6):753-71. PubMed ID: 458581
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
Garrett ER; Derendorf H; Mattha AG
J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs.
Garrett ER; Chandran VR
Biopharm Drug Dispos; 1990; 11(4):311-50. PubMed ID: 2340348
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.
Hinderling PH; Garrett ER; Wester RD
J Pharm Sci; 1977 Feb; 66(2):242-53. PubMed ID: 839422
[TBL] [Abstract][Full Text] [Related]
6. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of morphine and its surrogates. VIII: Naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine.
Garrett ER; Shyu WC; Ulubelen A
J Pharm Sci; 1986 Dec; 75(12):1127-36. PubMed ID: 3559921
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and oral 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride in the dog as a function of dose and characterization of metabolites.
Garrett ER; Van Peer A
J Pharm Sci; 1983 Sep; 72(9):1045-57. PubMed ID: 6631692
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of morphine and its surrogates IV: Pharmacokinetics of heroin and its derived metabolites in dogs.
Garrett ER; Gürkan T
J Pharm Sci; 1980 Oct; 69(10):1116-34. PubMed ID: 7420276
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model.
Bredberg U; Paalzow L
Pharm Res; 1990 Jan; 7(1):14-20. PubMed ID: 2300530
[TBL] [Abstract][Full Text] [Related]
14. Bioanalyses and pharmacokinetics of nafronyl in the dog.
Garrett ER
J Pharm Sci; 1984 May; 73(5):635-49. PubMed ID: 6737238
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, metabolism, and disposition of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.
Gombar CT; Straub K; Levandoski P; Gutzait L; Swagzdis J; Garvie C; Joseph G; Potts BD; Mico BA
Drug Metab Dispos; 1986; 14(5):540-8. PubMed ID: 2876859
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of [14C]rosaramicin in dogs.
Lin CC; Kim HK; Marco A; Radwanski E; Symchowicz S
Antimicrob Agents Chemother; 1986 May; 29(5):753-6. PubMed ID: 3729339
[TBL] [Abstract][Full Text] [Related]
17. Tolerance and disposition of tetrahydrocannabinol in man.
Hunt CA; Jones RT
J Pharmacol Exp Ther; 1980 Oct; 215(1):35-44. PubMed ID: 6256518
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of alpha-methyldopa in dogs.
Kochak GM; Mason WD
J Pharmacokinet Biopharm; 1985 Aug; 13(4):405-23. PubMed ID: 3841366
[TBL] [Abstract][Full Text] [Related]
19. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
Frantz SW; Ballantyne B; Leung HW
Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
[TBL] [Abstract][Full Text] [Related]
20. Plasma Pharmacokinetics and Routes of Excretion of [14C]-Labeled Arruva, a High-Potency Sweetener, Following Oral Administration to Beagle Dogs.
Casterton PL; Crincoli CM; Brathwaite WA; Rihner MO; Nikiforov AI; Thomas JA
Int J Toxicol; 2014 May; 33(3):238-245. PubMed ID: 24700569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
